Yugang Guo

机构：Sinovac Biotech, Zhejiang Pharmaceutical College, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0003-4499-8274

发表论文 58 篇 · 总被引 2389 次 · h-index 17

代表论文

• IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases (2024 · Nature Biotechnology · 被引 287)
• Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy (2021 · Nature Biomedical Engineering · 被引 271)
• Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma (2021 · Cell Death Discovery · 被引 135)
• The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer (2024 · Nature · 被引 130)
• A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy (2021 · Advanced Therapeutics · 被引 72)
• A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment (2023 · Frontiers in Oncology · 被引 54)